Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic...

Clinical Cancer Research 2014 / 04 Vol. 20; Iss. 8

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

Kennedy-Nasser, A. A., Ku, S., Castillo-Caro, P., Hazrat, Y., Wu, M.-F., Liu, H., Melenhorst, J., Barrett, A. J., Ito, S., Foster, A., Savoldo, B., Yvon, E., Carrum, G., Ramos, C. A., Krance, R. A., L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-13-3205
Date:
April, 2014
File:
PDF, 976 KB
english, 2014
Conversion to is in progress
Conversion to is failed